Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000655515 | SCV000777446 | uncertain significance | RYR1-related disorder | 2022-10-28 | criteria provided, single submitter | clinical testing | This variant, c.12960_12968del, results in the deletion of 3 amino acid(s) of the RYR1 protein (p.Arg4321_Leu4323del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (no rsID available, gnomAD 0.03%). This variant has been observed in individual(s) with nemaline myopathy by muscle biopsy (Invitae). ClinVar contains an entry for this variant (Variation ID: 544390). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Prevention |
RCV000721300 | SCV000852327 | uncertain significance | not provided | 2015-08-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002507137 | SCV002814484 | uncertain significance | Central core myopathy; Malignant hyperthermia, susceptibility to, 1; Congenital multicore myopathy with external ophthalmoplegia; Congenital myopathy with fiber type disproportion; King Denborough syndrome | 2021-07-29 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000721300 | SCV003814361 | uncertain significance | not provided | 2019-06-26 | criteria provided, single submitter | clinical testing |